Literature DB >> 31317323

Aptamer-based fluorometric determination for mucin 1 using gold nanoparticles and carbon dots.

Weiwei Wang1, Yan Wang2, Hong Pan1, Soumia Cheddah1, Chao Yan1.   

Abstract

A fluorometric method is described for the determination of mucin 1 (MUC1). It is based on the specific binding of MUC1 by anti-MUC1 aptamers and by exploiting the inner filter effect (IFE) exerted by gold nanoparticles (AuNPs) on the blue fluorescence of carbon dots (CDs). When CDs are mixed with AuNPs, their fluorescence is reduced due to an IFE. The IFE efficiency can be modulated by the adsorption and the aggregation state of AuNPs. The latter can be induced by addition of salt, thereby allowing the fluorescence of the CDs to recover. The aptamer is adsorbed on the AuNPs and protects the AuNPs from salt-induced aggregation which is accompanied by a color change from red to blue. If aptamer is added to a mixture of CDs and AuNPs in presence of salt, the aggregation of the AuNPs is inhibited. Thus, the blue fluorescence of the CDs (best measured at excitation/emission wavelengths of 365/448 nm) is reduced. If, however, the aptamers bind MUC1, the aptamers will be released from the surface of the AuNPs. This decreases the salt tolerance of AuNPs and leads to the recovery of the blue fluorescence. The fluorescence intensity increases with the concentration of MUC1. The method has a linear response in the 5.3 to 200 ng·mL-1 MUC1 concentration range and a lower detection limit of 5.3 ng·mL-1. The method displays excellent selectivity towards MUC1 against other proteins. Graphical abstract Schematic illustration of (I) the influence of IFE of free AuNPs and NaCl aggregated AuNPs and (II) the influence of specific interaction between MUC1 and aptamers on the NaCl-induced aggregation of AuNPs and the IFE efficiency.

Entities:  

Keywords:  Aptamer; Carbon dots; Fluorometric determination; Gold nanoparticles; Inner filter effect; Mucin 1; On-site detection

Year:  2019        PMID: 31317323     DOI: 10.1007/s00604-019-3516-4

Source DB:  PubMed          Journal:  Mikrochim Acta        ISSN: 0026-3672            Impact factor:   5.833


  5 in total

1.  Biochemical characterization of the soluble form of tumor antigen MUC1 isolated from sera and ascites fluid of breast and pancreatic cancer patients.

Authors:  P Beatty; F G Hanisch; D B Stolz; O J Finn; P Ciborowski
Journal:  Clin Cancer Res       Date:  2001-03       Impact factor: 12.531

2.  Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer.

Authors:  M Nacht; A T Ferguson; W Zhang; J M Petroziello; B P Cook; Y H Gao; S Maguire; D Riley; G Coppola; G M Landes; S L Madden; S Sukumar
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

3.  Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers.

Authors:  S Zhang; H S Zhang; V E Reuter; S F Slovin; H I Scher; P O Livingston
Journal:  Clin Cancer Res       Date:  1998-02       Impact factor: 12.531

4.  Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.

Authors:  M Medina; D Vélez; J A Asenjo; G Egea; F X Real; J Gil; J L Subiza
Journal:  Cancer Res       Date:  1999-03-01       Impact factor: 12.701

5.  Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.

Authors:  Y Kotera; J D Fontenot; G Pecher; R S Metzgar; O J Finn
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

  5 in total
  1 in total

Review 1.  Recent advancements in fabrication of nanomaterial based biosensors for diagnosis of ovarian cancer: a comprehensive review.

Authors:  Rinky Sha; Sushmee Badhulika
Journal:  Mikrochim Acta       Date:  2020-02-19       Impact factor: 5.833

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.